Back
#1
23.8%
Top 0.2%
19.0%
Top 12%
8.3%
Top 3%
6.9%
Top 0.6%
6.9%
Top 5%
4.1%
Top 73%
3.0%
Top 6%
2.1%
Top 0.4%
2.1%
Top 4%
1.4%
Top 96%
1.4%
Top 3%
1.4%
Top 6%
1.1%
Top 2%
1.1%
Top 16%
1.0%
Top 8%
0.8%
Top 7%
0.8%
MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify
2025-06-18
endocrinology
Title + abstract only
View on medRxiv
Show abstract
Maturity Onset Diabetes of the Young (MODY) can present after the age of 40yrs, but its prevalence, clinical characteristics, and the utility of simple clinical features for selecting cases in this age group remain poorly defined. We analysed whole-exome and clinical data from 51,619 individuals with diabetes diagnosed after 40 years of age from two large cohorts: the UK Biobank (n = 25,012) and the US health system MyCode cohort (n = 26,607). The prevalence of MODY due to pathogenic variants in...
Predicted journal destinations
1
Diabetologia
23 training papers
2
The Journal of Clinical Endocrinology & Metabolism
26 training papers
3
Nature Communications
483 training papers
4
eLife
262 training papers
5
Frontiers in Endocrinology
20 training papers
6
BMC Medicine
155 training papers
7
Scientific Reports
701 training papers
8
Nature Genetics
72 training papers
9
Communications Medicine
63 training papers
10
Human Molecular Genetics
28 training papers
11
PLOS ONE
1737 training papers
12
Cell Reports Medicine
49 training papers
13
JCI Insight
63 training papers
14
International Journal of Obesity
17 training papers
15
PLOS Medicine
95 training papers
16
Genome Medicine
56 training papers
17
The American Journal of Human Genetics
77 training papers